Line 22: | Line 22: | ||
<tr> | <tr> | ||
− | <td align="center"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--Duke--MikeProfilePic.jpg" style="width:220px;height:250px;"></td> | + | <td align="center"; width="50%"><img src="https://static.igem.org/mediawiki/2016/f/f8/T--Duke--MikeProfilePic.jpg" style="width:220px;height:250px;"></td> |
− | <td align="center"><h4>Michael Lynch</h4> | + | <td align="center"; width="50%"><h4>Michael Lynch</h4> |
<p><br>Michael Lynch MD, PhD is a rather attractive assistant professor of both Chemistry and Biomedical Engineering at Duke University. He received both his Ph.D and M.D. at the University of Colorado at Boulder. He always wears a blue lab coat and smiles with his perfect white teeth at everything, even when lab plans go awry. His research focuses on modifying bacterial pathways to produce chemicals essential for applications such as pharmacology and industry.</p> | <p><br>Michael Lynch MD, PhD is a rather attractive assistant professor of both Chemistry and Biomedical Engineering at Duke University. He received both his Ph.D and M.D. at the University of Colorado at Boulder. He always wears a blue lab coat and smiles with his perfect white teeth at everything, even when lab plans go awry. His research focuses on modifying bacterial pathways to produce chemicals essential for applications such as pharmacology and industry.</p> | ||
</td> | </td> |
Revision as of 17:11, 23 September 2017
Our Wonderful Team of Advisors
Advisors
Michael Lynch
|
|
Adim Moreb
|
|
John Decker
|
Mentors
Johnathon Burg
|
|
Zhixia Ye
|
|
Charlie Cooper
|
|
Jennifer Hennigan
|
|
Romel Menacho-Melgar
|
|
Daniel Rodriguez
|